PUBLISHER: The Business Research Company | PRODUCT CODE: 1705370
PUBLISHER: The Business Research Company | PRODUCT CODE: 1705370
Metoprolol tartrate is a beta-blocker medication primarily prescribed for managing conditions such as high blood pressure, angina (chest pain), heart failure, and as part of treatment following a heart attack. It functions by blocking the effects of natural chemicals such as epinephrine on the heart and blood vessels, thereby reducing blood pressure, heart rate, and cardiac strain. Additionally, metoprolol tartrate is used to prevent migraine headaches.
The medication is available for administration through oral and injectable routes. Oral metoprolol tartrate refers to formulations taken by mouth, typically in tablet or capsule form, and is utilized in treating hypertension, cardiovascular issues, and other medical conditions. Distribution channels for metoprolol tartrate include hospital pharmacies, retail pharmacies, and online pharmacies.
The metoprolol tartrate market research report is one of a series of new reports from The Business Research Company that provides metoprolol tartrate market statistics, including the metoprolol tartrate industry global market size, regional shares, competitors with metoprolol tartrate market share, detailed metoprolol tartrate market segments, market trends, and opportunities, and any further data you may need to thrive in the metoprolol tartrate industry. These metoprolol tartrate market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The metoprolol tartrate market size has grown strongly in recent years. It will grow from $6.41 billion in 2024 to $6.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising awareness about hypertension, expansion and improvement of healthcare systems, early patent protections, and health initiatives.
The metoprolol tartrate market size is expected to see strong growth in the next few years. It will grow to $8.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to personalized medicine, enhanced medical education and training on the management of cardiovascular diseases, development of efficient drug distribution networks, patient education programs and increased funding for cardiovascular research. Major trends in the forecast period include consumer behavior analysis, supply chain optimization, development of 3D printing technologies for customizable drug formulations, increasing development and use of mobile health apps.
The growth of the metoprolol tartrate market is expected to be driven by the rising prevalence of hypertension. Hypertension, a complex condition influenced by lifestyle, genetics, and underlying health issues, can develop gradually and is exacerbated by factors such as poor diet, lack of exercise, obesity, stress, and an aging population. Metoprolol tartrate manages hypertension by reducing heart rate and cardiac output, thereby lowering blood pressure. For example, the Australian Bureau of Statistics reported in December 2023 that 11.6% of the population, or approximately 3.0 million people, had hypertension in 2022, highlighting the significant driver behind the metoprolol tartrate market's growth.
The growing prevalence of coronary heart disease is expected to drive the expansion of the metoprolol tartrate market in the coming years. Coronary heart disease occurs when the blood vessels supplying the heart become narrowed due to plaque buildup, leading to reduced blood flow to the heart muscle, which can result in chest pain or even heart attacks. This condition is often caused by factors such as sedentary lifestyles, poor dietary choices, smoking, obesity, high blood pressure, and diabetes. Metoprolol tartrate helps manage coronary heart disease by lowering heart rate and blood pressure, preventing angina, protecting against acute coronary events, improving long-term health outcomes, and managing arrhythmias. For example, in October 2024, the Centers for Disease Control and Prevention (CDC) reported that one person dies every 33 seconds from cardiovascular disease, with 702,880 deaths from heart disease in 2022 alone, making it the cause of one in every five deaths. As a result, the rising prevalence of coronary heart disease is expected to boost the demand for metoprolol tartrate.
Leading companies in the metoprolol tartrate market are focusing on developing generic equivalents to offer cost-effective alternatives to branded medications for treating hypertension and cardiovascular conditions. These bioequivalent products provide the same therapeutic effects as their branded counterparts, ensuring similar absorption rates into the bloodstream. For example, Lupin Pharmaceuticals received approval from the FDA in August 2023 to market a generic equivalent of Toprol-XL Tablets, expanding their range of generic cardiovascular treatments in the U.S. market. This strategic approach aims to meet diverse patient needs with various tablet strengths indicated for hypertension and angina pectoris treatment.
Major companies operating in the metoprolol tartrate market are Pfizer Inc., AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Cipla Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd., Alembic Pharmaceuticals Inc., Accord Healthcare Inc., Beximco Pharmaceuticals Ltd., Micro Labs Ltd., Inventia Healthcare Pvt. Ltd., Watson Laboratories Inc., Aizant Drug Research Solutions Pvt. Ltd., Zydus Cadila, Validus Pharmaceuticals LLC, Strides Pharma Science Limited, APO-MEDIX Pty Ltd.
North America was the largest region in the metoprolol tartrate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metoprolol tartrate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the metoprolol tartrate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The metoprolol tartrate market consists of sales of extended-release tablets, lopressor, and intravenous formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Metoprolol Tartrate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on metoprolol tartrate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for metoprolol tartrate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metoprolol tartrate market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.